Research
Metabolic adaptation
GLP-1 analogs have shown efficacy in improving weight loss and cardiovascular risk factors.
Practitioners may consider GLP-1 analogs as a treatment option for weight management in menopausal women.
StrongSupportsmedium confidence
GLP-1 analogs have shown their efficacy in improving weight loss and other cardiovascular risk factors.
Why this rating
The claim is based on established knowledge in the field.
Source
Effectiveness of Low Doses of Semaglutide on Weight Loss and Body Composition Among Women in Their Menopause
Joana Nicolau et al. · Metabolic Syndrome and Related Disorders · 2025
otherCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →